JAZZ PEER ANALYSIS

Jazz Pharmaceuticals PLC — metric-by-metric comparison with peers and the industry median

JAZZJazz Pharmaceuticals PLC

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

JAZZIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	JAZZ	CSL	TLX	MSB	Ind. Median
P/E	545.67	29.44●	—	—	17.91
P/B	3.55	2.20●	6.37	—	3.51
EV/EBITDA	34.25	10.21●	120.14	—	14.82
P/S	3.63	2.62●	3.24	31.61	10.89

Financial Health
Metric	JAZZ	CSL	TLX	MSB	Ind. Median
Current Ratio	2.04	2.57●	1.43	—	5.90
Debt/Equity	119.5%	67.4%●	112.3%	—	10.9%
NetDebt/EBITDA	4.67	2.22●	13.13	—	1.15

Profitability
Metric	JAZZ	CSL	TLX	MSB	Ind. Median
Net Margin	0.7%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	0.7%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	0.3%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	12.3%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	JAZZ	CSL	TLX	MSB	Ind. Median
Rev. Growth	9.2%	4.8%	56.3%	410.4%●	5.1%
NI Growth	-93.9%	-39.4%●	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	JAZZ	MDGL	BBIO	EXEL	IONS	AXSM	Ind. Median
P/E	545.67	—	—	17.91●	—	—	17.91
P/B	3.55	28.21	-6.63●	7.71	27.24	229.14	3.51
EV/EBITDA	34.25	—	—	14.11	2.95●	—	14.82
P/S	3.63●	13.54	25.93	6.28	12.65	17.66	10.89

Financial Health
Metric	JAZZ	MDGL	BBIO	EXEL	IONS	AXSM	Ind. Median
Current Ratio	2.04	3.50	1.44	3.26	4.10●	1.39	5.90
Debt/Equity	119.5%	63.9%	-149.2%●	8.8%	415.3%	402.8%	10.9%
NetDebt/EBITDA	4.67	1.67	-4.02●	-0.60	0.03	0.49	1.15

Profitability
Metric	JAZZ	MDGL	BBIO	EXEL	IONS	AXSM	Ind. Median
Net Margin	0.7%	-27.3%	-125.2%	35.1%●	-30.9%	-26.6%	-125.7%
ROE	0.7%	-49.3%	—	41.0%●	-67.5%	-349.4%	-47.5%
ROA	0.3%	-27.8%	-64.5%	30.7%●	-10.4%	-28.7%	-35.8%
EBITDA Margin	12.3%	-24.8%	-105.0%	42.7%	433.5%●	-24.4%	-105.8%

Growth + Dividend
Metric	JAZZ	MDGL	BBIO	EXEL	IONS	AXSM	Ind. Median
Rev. Growth	9.2%	256.8%	355.2%●	3.3%	47.5%	63.9%	5.1%
NI Growth	-93.9%	—	—	29.5%●	—	—	12.1%
Div. Yield	—	—	—	—	0.2%	—	0.2%
Payout	—	—	—	—	-6.7%	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on JAZZ

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.